Kathleen O Lindell1, Zhan Liang2, Leslie A Hoffman2, Margaret Q Rosenzweig2, Melissa I Saul3, Joseph M Pilewski4, Kevin F Gibson5, Naftali Kaminski6. 1. The University of Pittsburgh Dorothy P. & Richard P. Simmons Center for Interstitial Lung Disease at UPMC, School of Medicine, Pittsburgh, PA; Division of Pulmonary, Allergy, and Critical Care Medicine, School of Medicine, Pittsburgh, PA. Electronic address: lindellko@upmc.edu. 2. School of Nursing, School of Medicine, Pittsburgh, PA. 3. Department of Biomedical Informatics, School of Medicine, Pittsburgh, PA. 4. Division of Pulmonary, Allergy, and Critical Care Medicine, School of Medicine, Pittsburgh, PA. 5. The University of Pittsburgh Dorothy P. & Richard P. Simmons Center for Interstitial Lung Disease at UPMC, School of Medicine, Pittsburgh, PA; Division of Pulmonary, Allergy, and Critical Care Medicine, School of Medicine, Pittsburgh, PA. 6. Pulmonary, Critical Care and Sleep Medicine, Yale School of Medicine, New Haven, CT.
Abstract
BACKGROUND: Palliative care, integrated early, may reduce symptom burden in patients with idiopathic pulmonary fibrosis (IPF). However, limited information exists on timing and clinical practice. The purpose of this study was to describe the time course of events prior to death in patients with IPF managed at a specialty center with a focus on location of death and timing of referral for palliative care. METHODS: Data were retrospectively extracted from the health system's data repository and obituary listings. The sample included all decedents, excluding lung transplant recipients, who had their first visit to the center between 2000 and 2012. RESULTS: Median survival for 404 decedents was 3 years from diagnosis and 1 year from first center visit. Of 277 decedents whose location of death could be determined, > 50% died in the hospital (57%). Only 38 (13.7%) had a formal palliative care referral and the majority (71%) was referred within 1 month of their death. Decedents who died in the academic medical center ICU were significantly younger than those who died in a community hospital ward (P = .04) or hospice (P = .001). CONCLUSIONS: The majority of patients with IPF died in a hospital setting and only a minority received a formal palliative care referral. Referral to palliative care occurred late in the disease. These findings indicate the need to study adequacy of end-of-life management in IPF and promote earlier discussion and referral to palliative care.
BACKGROUND: Palliative care, integrated early, may reduce symptom burden in patients with idiopathic pulmonary fibrosis (IPF). However, limited information exists on timing and clinical practice. The purpose of this study was to describe the time course of events prior to death in patients with IPF managed at a specialty center with a focus on location of death and timing of referral for palliative care. METHODS: Data were retrospectively extracted from the health system's data repository and obituary listings. The sample included all decedents, excluding lung transplant recipients, who had their first visit to the center between 2000 and 2012. RESULTS: Median survival for 404 decedents was 3 years from diagnosis and 1 year from first center visit. Of 277 decedents whose location of death could be determined, > 50% died in the hospital (57%). Only 38 (13.7%) had a formal palliative care referral and the majority (71%) was referred within 1 month of their death. Decedents who died in the academic medical center ICU were significantly younger than those who died in a community hospital ward (P = .04) or hospice (P = .001). CONCLUSIONS: The majority of patients with IPF died in a hospital setting and only a minority received a formal palliative care referral. Referral to palliative care occurred late in the disease. These findings indicate the need to study adequacy of end-of-life management in IPF and promote earlier discussion and referral to palliative care.
Authors: Sabrina Bajwah; Irene J Higginson; Joy R Ross; Athol U Wells; Surinder S Birring; Amit Patel; Julia Riley Journal: Lung Date: 2012-01-05 Impact factor: 2.584
Authors: Harold R Collard; Gregory Tino; Paul W Noble; Mark A Shreve; Maureen Michaels; Bruce Carlson; Marvin I Schwarz Journal: Respir Med Date: 2006-11-14 Impact factor: 3.415
Authors: Kathleen O Lindell; Margaret Q Rosenzweig; Joseph Pilewski; Leslie A Hoffman; Kevin Gibson; Naftali Kaminski Journal: Chest Date: 2015-08 Impact factor: 9.410
Authors: Kathleen Oare Lindell; Dio Kavalieratos; Kevin F Gibson; Laura Tycon; Margaret Rosenzweig Journal: Heart Lung Date: 2016-11-18 Impact factor: 2.210
Authors: Rebecca A Aslakson; Lynn F Reinke; Christopher Cox; Erin K Kross; Roberto P Benzo; J Randall Curtis Journal: J Palliat Med Date: 2017-04 Impact factor: 2.947